Status:
COMPLETED
To Differentiate Focal Autoimmune Pancreatitis From Pancreatic Cancer by Endoscopic Ultrasound
Lead Sponsor:
Peking Union Medical College Hospital
Collaborating Sponsors:
Tianjin Medical University General Hospital
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Conditions:
Autoimmune Pancreatitis
Pancreatic Cancer
Eligibility:
All Genders
Up to 75 years
Brief Summary
Autoimmune pancreatitis (AIP) is a special type of chronic pancreatitis mediated by autoimmunity. The classic manifestation of AIP is diffuse pancreatic enlargement, some of which are characterized by...
Detailed Description
A derivation sample is established by retrospectively collecting the EUS images of about 100 FAIP patients and about 200 PC patients who were diagnosed for the first time in Peking Union Medical Colle...
Eligibility Criteria
Inclusion
- Patients with difficulty in distinguishing between FAIP and PC
Exclusion
- Referred patients with a history of having being conclusively diagnosed as AIP or PC; Patients with DAIP; Patients with alcoholic pancreatitis, hypertriglyceridemia pancreatitis or pancreatitis due to gallstones; Patients with pancreatic cystic tumors, pancreatic neuroendocrine tumors or solid pseudopapillary tumors of pancreas; Patients who cannot undergo EUS due to unsuitable conditions.
Key Trial Info
Start Date :
May 11 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2024
Estimated Enrollment :
286 Patients enrolled
Trial Details
Trial ID
NCT04834505
Start Date
May 11 2021
End Date
December 30 2024
Last Update
May 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China, 100730